Amino acid transporters revisited: New views in health and disease.
暂无分享,去创建一个
[1] M. Hediger,et al. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system. , 2018, Journal of pharmacological and toxicological methods.
[2] C. Göritz,et al. Glutamate transporter Slc1a3 mediates inter‐niche stem cell activation during skin growth , 2018, The EMBO journal.
[3] R. Jahn,et al. Dual and Direction-Selective Mechanisms of Phosphate Transport by the Vesicular Glutamate Transporter. , 2018, Cell reports.
[4] H. Daniel,et al. NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosis , 2018, Scientific Reports.
[5] D. Merlin,et al. Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease. , 2018, Comprehensive Physiology.
[6] T. Gonen,et al. Crystal structure of arginine-bound lysosomal transporter SLC38A9 in the cytosol-open state , 2018, Nature Structural & Molecular Biology.
[7] C. Löw,et al. Multispecific Substrate Recognition in a Proton-Dependent Oligopeptide Transporter , 2018, Structure.
[8] L. Coutellier,et al. Changes in the Prefrontal Glutamatergic and Parvalbumin Systems of Mice Exposed to Unpredictable Chronic Stress , 2017, Molecular Neurobiology.
[9] H. S. Hundal,et al. Effects of Sodium and Amino Acid Substrate Availability upon the Expression and Stability of the SNAT2 (SLC38A2) Amino Acid Transporter , 2018, Front. Pharmacol..
[10] S. Newstead,et al. Structural basis for amino acid transport by the CAT family of SLC7 transporters , 2018, Nature Communications.
[11] E. Lee,et al. Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses , 2018, Front. Immunol..
[12] P. Gasparini,et al. Mutations in L-type amino acid transporter-2 support SLC7A8 as a novel gene involved in age-related hearing loss , 2018, eLife.
[13] Joe T. Sharick,et al. Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models , 2017, Nature Medicine.
[14] G. Voth,et al. Proton movement and coupling in the POT family of peptide transporters , 2017, Proceedings of the National Academy of Sciences.
[15] D. Thwaites,et al. Resculpting the binding pocket of APC superfamily LeuT-fold amino acid transporters , 2017, Cellular and Molecular Life Sciences.
[16] Gregory A. Wyant,et al. mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient , 2017, Cell.
[17] F. Abe,et al. Functional analysis of human aromatic amino acid transporter MCT10/TAT1 using the yeast Saccharomyces cerevisiae. , 2017, Biochimica et biophysica acta. Biomembranes.
[18] Min Liu,et al. Molecular mechanism of substrate recognition and transport by the AtSWEET13 sugar transporter , 2017, Proceedings of the National Academy of Sciences.
[19] D. Calvisi,et al. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis , 2017, Hepatology.
[20] A. Murphy,et al. Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice. , 2017, Cell metabolism.
[21] D. Levy,et al. Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease. , 2017, Kidney international.
[22] Simone Brogi,et al. Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators. , 2017, Journal of medicinal chemistry.
[23] M. Bianchi,et al. GPNA inhibits the sodium-independent transport system l for neutral amino acids , 2017, Amino Acids.
[24] M. Kavanaugh,et al. Photoswitchable Inhibitor of a Glutamate Transporter. , 2017, ACS chemical neuroscience.
[25] K. Rajapakshe,et al. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer , 2017, Molecular Cancer Research.
[26] Kenji F. Tanaka,et al. OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior , 2017, Proceedings of the National Academy of Sciences.
[27] J. Mi,et al. Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1. , 2017, Cancer letters.
[28] V. Prado,et al. Cholinergic/glutamatergic co‐transmission in striatal cholinergic interneurons: new mechanisms regulating striatal computation , 2017, Journal of neurochemistry.
[29] M. Jadot,et al. SNAT7 is the primary lysosomal glutamine exporter required for extracellular protein-dependent growth of cancer cells , 2017, Proceedings of the National Academy of Sciences.
[30] Christian Rosenmund,et al. Characterization of a Human Point Mutation of VGLUT3 (p.A211V) in the Rodent Brain Suggests a Nonuniform Distribution of the Transporter in Synaptic Vesicles , 2017, The Journal of Neuroscience.
[31] A. Frick,et al. Abnormal wiring of CCK+ basket cells disrupts spatial information coding , 2017, Nature Neuroscience.
[32] I. Eberini,et al. Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation. , 2017, Biochimica et biophysica acta. General subjects.
[33] R. Salomon,et al. Renal involvement in lysinuric protein intolerance: contribution of pathology to assessment of heterogeneity of renal lesions. , 2017, Human pathology.
[34] L. Abrahmsén,et al. Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation , 2017, Nature Communications.
[35] R. Zoncu,et al. Lysosomal cholesterol activates mTORC1 via an SLC38A9–Niemann-Pick C1 signaling complex , 2017, Science.
[36] Naomi R. Latorraca,et al. Mechanism of Substrate Translocation in an Alternating Access Transporter , 2017, Cell.
[37] G. Krause,et al. Thyroid hormone transport across L-type amino acid transporters: What can molecular modelling tell us? , 2017, Molecular and Cellular Endocrinology.
[38] N. Reyes,et al. Structure and allosteric inhibition of excitatory amino acid transporter 1 , 2017, Nature.
[39] M. A. Sutton,et al. Vesicular Glutamate Transporter Inhibitors: Structurally Modified Brilliant Yellow Analogs , 2017, Neurochemical Research.
[40] H. Williams,et al. Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay , 2017, Journal of Inherited Metabolic Disease.
[41] P. Luppi,et al. Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep behaviour disorder , 2017, Brain : a journal of neurology.
[42] J. Morrison,et al. Age and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole , 2017, Molecular Psychiatry.
[43] S. Scheuring,et al. Direct visualization of glutamate transporter elevator mechanism by high-speed AFM , 2017, Proceedings of the National Academy of Sciences.
[44] Jun Wan,et al. The amino acid transporter SLC36A4 regulates the amino acid pool in retinal pigmented epithelial cells and mediates the mechanistic target of rapamycin, complex 1 signaling , 2017, Aging cell.
[45] M. Hirata,et al. Integrated analysis of miRNA and mRNA gene expression microarrays: Influence on platelet reactivity, clopidogrel response and drug-induced toxicity. , 2016, Gene.
[46] Ji-Soo Kim,et al. Late-onset episodic ataxia associated with SLC1A3 mutation , 2016, Journal of Human Genetics.
[47] H. Yoo,et al. Biochemical and molecular characteristics of citrin deficiency in Korean children , 2016, Journal of Human Genetics.
[48] Huajun Fan,et al. MicroRNA-593-3p regulates insulin-promoted glucose consumption by targeting Slc38a1 and CLIP3. , 2016, Journal of molecular endocrinology.
[49] Jun Yu,et al. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. , 2016, Gastroenterology.
[50] M. Mattson,et al. The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons , 2016, Scientific Reports.
[51] A. De Grassi,et al. AGC1/2, the mitochondrial aspartate-glutamate carriers. , 2016, Biochimica et biophysica acta.
[52] Lori A. Coburn,et al. The L-Arginine Transporter Solute Carrier Family 7 Member 2 Mediates the Immunopathogenesis of Attaching and Effacing Bacteria , 2016, PLoS pathogens.
[53] Y. Bhutia,et al. Glutamine transporters in mammalian cells and their functions in physiology and cancer. , 2016, Biochimica et biophysica acta.
[54] H. Kuwano,et al. Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma , 2016, Cancer science.
[55] J. Park,et al. Polymorphisms in cancer-related pathway genes and lung cancer , 2016, European Respiratory Journal.
[56] Michael R. Johnson,et al. De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies. , 2016, American journal of human genetics.
[57] P. Rathjen,et al. Regulation of amino acid transporters in pluripotent cell populations in the embryo and in culture; novel roles for sodium-coupled neutral amino acid transporters , 2016, Mechanisms of Development.
[58] F. Alkuraya,et al. Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans , 2016, Human Genetics.
[59] G. D. De Benedetto,et al. Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia* , 2016, The Journal of Biological Chemistry.
[60] C. Wagner,et al. Regulation and function of the SLC38A3/SNAT3 glutamine transporter , 2016, Channels.
[61] J. Köhrle,et al. Few Amino Acid Exchanges Expand the Substrate Spectrum of Monocarboxylate Transporter 10. , 2016, Molecular endocrinology.
[62] R. Edwards,et al. Protons Regulate Vesicular Glutamate Transporters through an Allosteric Mechanism , 2016, Neuron.
[63] S. Bröer,et al. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells* , 2016, The Journal of Biological Chemistry.
[64] R. Evans,et al. ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells. , 2016, Cell metabolism.
[65] T. Herbert,et al. System-L amino acid transporters play a key role in pancreatic β-cell signalling and function. , 2016, Journal of molecular endocrinology.
[66] Y. Aoki,et al. Mitochondrial Aspartate/Glutamate Carrier SLC25A12 and Autism Spectrum Disorder: a Meta-Analysis , 2016, Molecular Neurobiology.
[67] M. Leuenberger,et al. Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes. , 2016, ACS chemical neuroscience.
[68] Kohei Hagiwara,et al. Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging , 2016, Cancer science.
[69] Tom R. Gaunt,et al. Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels , 2016, Nature Communications.
[70] S. Bröer,et al. Loss of function mutation of the Slc38a3 glutamine transporter reveals its critical role for amino acid metabolism in the liver, brain, and kidney , 2016, Pflügers Archiv - European Journal of Physiology.
[71] R. Jaenisch,et al. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity , 2015, eLife.
[72] S. Kuyucak,et al. Computational Studies of Glutamate Transporters , 2015, Biomolecules.
[73] M. Skowrońska,et al. Induction of inducible nitric oxide synthase expression in ammonia‐exposed cultured astrocytes is coupled to increased arginine transport by upregulated y+LAT2 transporter , 2015, Journal of neurochemistry.
[74] Christian M. Metallo,et al. Branched chain amino acid catabolism fuels adipocyte differentiation and lipogenesis , 2015, Nature chemical biology.
[75] Lily S. Cheung,et al. Structure of a eukaryotic SWEET transporter in a homotrimeric complex , 2015, Nature.
[76] W. Ritchie,et al. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer , 2015, Oncogene.
[77] D. Lancet,et al. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum , 2015, Clinical genetics.
[78] Christian Gieger,et al. Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality , 2015, PLoS genetics.
[79] M. Ruberg,et al. Hypomorphic variants of cationic amino acid transporter 3 in males with autism spectrum disorders , 2015, Amino Acids.
[80] M. Kitazawa,et al. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease , 2015, Neurobiology of Aging.
[81] Jun Liu,et al. Association between genetic variants in SLC25A12 and risk of autism spectrum disorders: An integrated meta‐analysis , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[82] V. Haroutunian,et al. Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia , 2015, Translational Psychiatry.
[83] M. Monné,et al. Mitochondrial transporters for ornithine and related amino acids: a review , 2015, Amino Acids.
[84] M. Nandave,et al. Emerging roles of system antiporter and its inhibition in CNS disorders , 2015, Molecular membrane biology.
[85] A. Serra,et al. Impaired expression of key molecules of ammoniagenesis underlies renal acidosis in a rat model of chronic kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[86] U. Sundaram,et al. Mast cell regulation of Na-glutamine co-transporters B0AT1 in villus and SN2 in crypt cells during chronic intestinal inflammation , 2015, BMC Gastroenterology.
[87] M. Gleave,et al. Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development , 2015, The Journal of pathology.
[88] R. Fredriksson,et al. Transport of L-glutamine, L-alanine, L-arginine and L-histidine by the neuron-specific Slc38a8 (SNAT8) in CNS. , 2015, Journal of molecular biology.
[89] A. V. Vulto-van Silfhout,et al. Homozygous SLC6A17 mutations cause autosomal-recessive intellectual disability with progressive tremor, speech impairment, and behavioral problems. , 2015, American journal of human genetics.
[90] I. Kato,et al. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2 , 2015, Cancer science.
[91] R. Fingerhut,et al. Essential amino acid transporter Lat4 (Slc43a2) is required for mouse development , 2015, The Journal of physiology.
[92] H. S. Hundal,et al. Proteasomal Modulation of Cellular SNAT2 (SLC38A2) Abundance and Function by Unsaturated Fatty Acid Availability* , 2015, The Journal of Biological Chemistry.
[93] Qinghua Wang,et al. GABAergic system in the endocrine pancreas: a new target for diabetes treatment , 2015, Diabetes, metabolic syndrome and obesity : targets and therapy.
[94] S. Oliet,et al. Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission , 2015, Nature Neuroscience.
[95] Toshiharu Suzuki,et al. Vesicular Glutamate Transporters Use Flexible Anion and Cation Binding Sites for Efficient Accumulation of Neurotransmitter , 2014, Neuron.
[96] Thijs J. Hagenbeek,et al. L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia , 2014, Leukemia.
[97] G. Superti-Furga,et al. SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1 , 2014, Nature.
[98] A. McQuillin,et al. Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia , 2014, European Journal of Human Genetics.
[99] M. Nakajima,et al. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia. , 2014, Biochemical and biophysical research communications.
[100] E. Fukusaki,et al. Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion , 2014, Cell reports.
[101] S. Yokoyama,et al. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. , 2014, Immunity.
[102] E. Foran,et al. Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization , 2014, Glia.
[103] C. Kahn,et al. ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes , 2014, Science Translational Medicine.
[104] P. Nordlund,et al. Selectivity mechanism of a bacterial homolog of the human drug-peptide transporters PepT1 and PepT2 , 2014, Nature Structural &Molecular Biology.
[105] R. Chen,et al. The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation , 2014, The Journal of cell biology.
[106] T. Salt,et al. Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex , 2014, Neurochemistry International.
[107] A. Ortega,et al. Expression of the System N transporter (SNAT5/SN2) during development indicates its plausible role in glutamatergic neurotransmission , 2014, Neurochemistry International.
[108] J. Lyons,et al. Structural basis for polyspecificity in the POT family of proton-coupled oligopeptide transporters , 2014, EMBO reports.
[109] K. Sugden,et al. Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex , 2014, Synapse.
[110] S. Welford,et al. Expression of Glutamine Transporter Slc38a3 (SNAT3) During Acidosis is Mediated by a Different Mechanism than Tissue-Specific Expression , 2014, Cellular Physiology and Biochemistry.
[111] J. Rasko,et al. Monoterpene Glycoside ESK246 from Pittosporum Targets LAT3 Amino Acid Transport and Prostate Cancer Cell Growth , 2014, ACS chemical biology.
[112] Jinyu Wu,et al. SLC7A14 linked to autosomal recessive retinitis pigmentosa , 2014, Nature Communications.
[113] E. Gouaux,et al. How LeuT shapes our understanding of the mechanisms of sodium‐coupled neurotransmitter transporters , 2014, The Journal of physiology.
[114] L. Cantley,et al. Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome , 2014, Cell.
[115] Kristin Arnsburg,et al. Interrelation Between Protein Synthesis, Proteostasis and Life Span , 2014, Current genomics.
[116] G. Parisi,et al. UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation , 2014, Proceedings of the National Academy of Sciences.
[117] John Bradbury,et al. Recessive mutations in SLC38A8 cause foveal hypoplasia and optic nerve misrouting without albinism. , 2013, American journal of human genetics.
[118] T. Rauen,et al. Functional Properties of the Retinal Glutamate Transporters GLT-1c and EAAT5* , 2013, The Journal of Biological Chemistry.
[119] L. F. Waanders,et al. Proteome Analysis and Conditional Deletion of the EAAT2 Glutamate Transporter Provide Evidence against a Role of EAAT2 in Pancreatic Insulin Secretion in Mice* , 2013, The Journal of Biological Chemistry.
[120] Jun Liu,et al. SLC3A1 and SLC7A9 mutations in autosomal recessive or dominant canine cystinuria: a new classification system. , 2013, Journal of veterinary internal medicine.
[121] M. Gleave,et al. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development. , 2013, Journal of the National Cancer Institute.
[122] C. Caggese,et al. Mitochondrial glutamate carriers from Drosophila melanogaster: biochemical, evolutionary and modeling studies. , 2013, Biochimica et biophysica acta.
[123] O. Birk,et al. Isolated foveal hypoplasia with secondary nystagmus and low vision is associated with a homozygous SLC38A8 mutation , 2013, European Journal of Human Genetics.
[124] G. Uhl,et al. Involvement of the Neutral Amino Acid Transporter SLC6A15 and Leucine in Obesity-Related Phenotypes , 2013, PloS one.
[125] M. Rietschel,et al. Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[126] P. Nordlund,et al. Structural insights into substrate recognition in proton‐dependent oligopeptide transporters , 2013, EMBO reports.
[127] S. Nikkari,et al. Contribution of SLC7A1 genetic variant to hypertension, the TAMRISK study , 2013, BMC Medical Genetics.
[128] T. Oyama,et al. Diagnostic usefulness of 18F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[129] Y. Sugita,et al. Structural basis for dynamic mechanism of proton-coupled symport by the peptide transporter POT , 2013, Proceedings of the National Academy of Sciences.
[130] S. Lipton,et al. Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss , 2013, Proceedings of the National Academy of Sciences.
[131] Edmund R. S. Kunji,et al. Lipid, Detergent, and Coomassie Blue G-250 Affect the Migration of Small Membrane Proteins in Blue Native Gels , 2013, The Journal of Biological Chemistry.
[132] J. Foster,et al. SLC6 transporters: structure, function, regulation, disease association and therapeutics. , 2013, Molecular aspects of medicine.
[133] M. Leuenberger,et al. The SLC1 high-affinity glutamate and neutral amino acid transporter family. , 2013, Molecular aspects of medicine.
[134] M. Hediger,et al. The ABCs of membrane transporters in health and disease (SLC series): Introduction , 2013, Molecular aspects of medicine.
[135] R. Reimer. SLC17: a functionally diverse family of organic anion transporters. , 2013, Molecular aspects of medicine.
[136] D. Fotiadis,et al. The SLC3 and SLC7 families of amino acid transporters. , 2013, Molecular aspects of medicine.
[137] A. Sali,et al. Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1 , 2013, Proceedings of the National Academy of Sciences of the United States of America.
[138] B. Beutler,et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus , 2013, Proceedings of the National Academy of Sciences.
[139] M. Rodríguez-Moran,et al. Association of the polymorphisms 292 C>T and 1304 G>A in the SLC38A4 gene with hyperglycaemia , 2013, Diabetes/metabolism research and reviews.
[140] M. Malumbres,et al. HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. , 2012, Molecular cell.
[141] M. Palacín,et al. T‐type amino acid transporter TAT1 (Slc16a10) is essential for extracellular aromatic amino acid homeostasis control , 2012, The Journal of physiology.
[142] L. Bunch,et al. Design, synthesis and pharmacological characterization of coumarin-based fluorescent analogs of excitatory amino acid transporter subtype 1 selective inhibitors, UCPH-101 and UCPH-102. , 2012, Bioorganic & medicinal chemistry.
[143] B. André,et al. Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy , 2012, Proceedings of the National Academy of Sciences.
[144] P. Finan,et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. , 2012, Molecular cell.
[145] Keigo Endo,et al. Transport of 3-Fluoro-l-α-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET , 2012, The Journal of Nuclear Medicine.
[146] B. Liu,et al. LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis , 2012, Science.
[147] A. Pinto,et al. Mechanism of inhibition of the glutamate transporter EAAC1 by the conformationally constrained glutamate analogue (+)-HIP-B. , 2012, Biochemistry.
[148] M. Topf,et al. Mutations in the GlyT2 Gene (SLC6A5) Are a Second Major Cause of Startle Disease* , 2012, The Journal of Biological Chemistry.
[149] R. Boldrini,et al. Distribution of cystinosin-LKG in human tissues , 2012, Histochemistry and Cell Biology.
[150] V. Saudek. Cystinosin, MPDU1, SWEETs and KDELR Belong to a Well-Defined Protein Family with Putative Function of Cargo Receptors Involved in Vesicle Trafficking , 2012, PloS one.
[151] A. Robinson,et al. Substrate Specificity of the Two Mitochondrial Ornithine Carriers Can Be Swapped by Single Mutation in Substrate Binding Site* , 2012, The Journal of Biological Chemistry.
[152] G. Bellenchi,et al. Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin , 2012, Proceedings of the National Academy of Sciences.
[153] C. Perez,et al. Role of bundle helices in a regulatory crosstalk in the trimeric betaine transporter BetP. , 2011, Journal of molecular biology.
[154] Stephan J Sanders,et al. Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE. , 2011, Human molecular genetics.
[155] M. Glicksman,et al. Structure-activity relationship study of pyridazine derivatives as glutamate transporter EAAT2 activators. , 2011, Bioorganic & medicinal chemistry letters.
[156] P. Newsholme,et al. L-arginine is essential for pancreatic β-cell functional integrity, metabolism and defense from inflammatory challenge. , 2011, The Journal of endocrinology.
[157] D. Attwell,et al. A Role for Glutamate Transporters in the Regulation of Insulin Secretion , 2011, PloS one.
[158] V. Ganapathy,et al. SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer* , 2011, The Journal of Biological Chemistry.
[159] S. Bröer,et al. The role of amino acid transporters in inherited and acquired diseases. , 2011, The Biochemical journal.
[160] S. Golz,et al. OAT2 catalyses efflux of glutamate and uptake of orotic acid. , 2011, The Biochemical journal.
[161] Ignacio Fita,et al. Crystal structure of a substrate-bound amino acid antiporter in the outward open conformation: mechanism of substrate recognintion and transport. , 2011 .
[162] R. Vandenberg,et al. Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. , 2011, The Journal of clinical investigation.
[163] C. Bundgaard,et al. Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101). , 2010, Journal of medicinal chemistry.
[164] E. Tajkhorshid,et al. Identification of the third Na+ site and the sequence of extracellular binding events in the glutamate transporter. , 2010, Biophysical journal.
[165] Lorenz C. Blum,et al. Identification of selective norbornane-type aspartate analogue inhibitors of the glutamate transporter 1 (GLT-1) from the chemical universe generated database (GDB). , 2010, Journal of medicinal chemistry.
[166] S. Bröer,et al. Renal imino acid and glycine transport system ontogeny and involvement in developmental iminoglycinuria. , 2010, The Biochemical journal.
[167] H. Shin,et al. A new association between polymorphisms of the SLC6A7 gene in the chromosome 5q31–32 region and asthma , 2010, Journal of Human Genetics.
[168] K. Seyb,et al. Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening , 2010, Journal of biomolecular screening.
[169] J. Ko,et al. Novel mutation in SLC6A19 causing late-onset seizures in Hartnup disorder. , 2010, Pediatric neurology.
[170] Yigong Shi,et al. Mechanism of substrate recognition and transport by an amino acid antiporter , 2010, Nature.
[171] N. Reyes,et al. Transport mechanism of a bacterial homologue of glutamate transporters , 2009, Nature.
[172] H. Daniel,et al. Projection structure of DtpD (YbgH), a prokaryotic member of the peptide transporter family. , 2009, Journal of molecular biology.
[173] Ying Wang,et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.
[174] A. Hofman,et al. The Neuronal Transporter Gene SLC6A15 Confers Risk to Major Depression , 2011, Neuron.
[175] E. Gouaux,et al. Structure and Mechanism of a Na+-Independent Amino Acid Transporter , 2009, Science.
[176] Yigong Shi,et al. Structure and Mechanism of an Amino Acid Antiporter , 2009, Science.
[177] M. Baumgartner,et al. Identification of novel mutations in the SLC25A15 gene in hyperornithinemia‐hyperammonemia‐homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study , 2009, Human mutation.
[178] Adiel Cohen,et al. An Amino Acid Shuffle Activates mTORC1 , 2009, Cell.
[179] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[180] Eric Gouaux,et al. A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation , 2008, Science.
[181] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[182] S. Bröer,et al. Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. , 2008, The Journal of clinical investigation.
[183] H. Nury,et al. Mitochondrial bovine ADP/ATP carrier in detergent is predominantly monomeric but also forms multimeric species. , 2008, Biochemistry.
[184] M. Tomi,et al. Evaluation of amino acid-mustard transport as L-type amino acid transporter 1 (LAT1)-mediated alkylating agents. , 2008, Biological & pharmaceutical bulletin.
[185] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[186] L. Mannucci,et al. Identification and subcellular localization of a new cystinosin isoform. , 2008, American journal of physiology. Renal physiology.
[187] M. Gobbi,et al. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. , 2008, European journal of pharmacology.
[188] S. Amara,et al. Enhancing Glutamate Transport: Mechanism of Action of Parawixin1, a Neuroprotective Compound from Parawixia bistriata Spider Venom , 2007, Molecular Pharmacology.
[189] Emily F. Stone,et al. The Glutamate and Chloride Permeation Pathways Are Colocalized in Individual Neuronal Glutamate Transporter Subunits , 2007, The Journal of Neuroscience.
[190] H. Larsson,et al. The Glutamate-Activated Anion Conductance in Excitatory Amino Acid Transporters Is Gated Independently by the Individual Subunits , 2007, The Journal of Neuroscience.
[191] Eric Gouaux,et al. Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter , 2007, Nature.
[192] T. Usui,et al. Brasilicardin A, a natural immunosuppressant, targets amino Acid transport system L. , 2006, Chemistry & biology.
[193] Masahiko Watanabe,et al. Indispensability of the glutamate transporters GLAST and GLT1 to brain development , 2006, Proceedings of the National Academy of Sciences.
[194] C. Fahlke,et al. Intersubunit Interactions in EAAT4 Glutamate Transporters , 2006, The Journal of Neuroscience.
[195] Anita Shah,et al. System B0,+ amino acid transport regulates the penetration stage of blastocyst implantation with possible long-term developmental consequences through adulthood. , 2006, Human reproduction update.
[196] B. van Yserloo,et al. Identification and characterization of a novel isoform of the vesicular gamma-aminobutyric acid transporter with glucose-regulated expression in rat islets. , 2006, Journal of molecular endocrinology.
[197] L. Bunch,et al. Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3. , 2006, Journal of medicinal chemistry.
[198] Q. Lu,et al. Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2. , 2005, Bioorganic & medicinal chemistry letters.
[199] K. Fan,et al. Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2 , 2005, Molecular Pharmacology.
[200] T. Rauen,et al. Individual subunits of the glutamate transporter EAAC1 homotrimer function independently of each other. , 2005, Biochemistry.
[201] R. Bridges,et al. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes. , 2005, Pharmacology & therapeutics.
[202] E. Gouaux,et al. Structure of a glutamate transporter homologue from Pyrococcus horikoshii , 2004, Nature.
[203] E. Closs,et al. Plasma membrane transporters for arginine. , 2004, The Journal of nutrition.
[204] N. Curthoys,et al. Glutamine metabolism: Role in acid‐base balance * , 2004, Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology.
[205] S. Amara,et al. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. , 2004, Molecular pharmacology.
[206] H. Sitte,et al. Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. , 2004, Molecular interventions.
[207] Kaisa Silander,et al. The SLC6A14 gene shows evidence of association with obesity. , 2003, The Journal of clinical investigation.
[208] S. Eliasof,et al. WAY‐855 (3‐amino‐tricyclo[2.2.1.02.6]heptane‐1,3‐dicarboxylic acid): a novel, EAAT2‐preferring, nonsubstrate inhibitor of high‐affinity glutamate uptake , 2003, British journal of pharmacology.
[209] John E. Walker,et al. The Mitochondrial Ornithine Transporter , 2003, Journal of Biological Chemistry.
[210] S. Amara,et al. Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake , 2003, British journal of pharmacology.
[211] S. Bröer. Adaptation of plasma membrane amino acid transport mechanisms to physiological demands , 2002, Pflügers Archiv.
[212] Y. Kanai,et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. , 2002, Molecular pharmacology.
[213] C. Meier,et al. Activation of system L heterodimeric amino acid exchangers by intracellular substrates , 2002, The EMBO journal.
[214] C. Antignac,et al. Cystinosin, the protein defective in cystinosis, is a H+‐driven lysosomal cystine transporter , 2001, The EMBO journal.
[215] B. Bode. Recent molecular advances in mammalian glutamine transport. , 2001, The Journal of nutrition.
[216] M. Yudkoff,et al. The glutamine/glutamate couplet and cellular function. , 2001, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[217] Y. Kanai,et al. Expression Cloning of a Na+-independent Aromatic Amino Acid Transporter with Structural Similarity to H+/Monocarboxylate Transporters* , 2001, The Journal of Biological Chemistry.
[218] C. Antignac,et al. The Targeting of Cystinosin to the Lysosomal Membrane Requires a Tyrosine-based Signal and a Novel Sorting Motif* , 2001, The Journal of Biological Chemistry.
[219] V. Ganapathy,et al. Evidence for the transport of neutral as well as cationic amino acids by ATA3, a novel and liver-specific subtype of amino acid transport system A. , 2001, Biochimica et biophysica acta.
[220] M. López-Fontanals,et al. The role of system A for neutral amino acid transport in the regulation of cell volume , 2001, Molecular membrane biology.
[221] Y. Shigeri,et al. Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockers. , 2000, Bioorganic & medicinal chemistry letters.
[222] T. Tsuruo,et al. The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier , 2000, Brain Research.
[223] M. Hediger,et al. Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1. , 2000, Biochemical and biophysical research communications.
[224] I. Paulsen,et al. New Glycoprotein-Associated Amino Acid Transporters , 1999, The Journal of Membrane Biology.
[225] C. Antignac,et al. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. , 1999, Human molecular genetics.
[226] M. Kavanaugh,et al. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. , 1999, Molecular pharmacology.
[227] M. Hediger. Glutamate transporters in kidney and brain. , 1999, American journal of physiology. Renal physiology.
[228] J. Matthews,et al. Glutamate transport and renal function. , 1999, American journal of physiology. Renal physiology.
[229] M. Hediger,et al. Introduction: glutamate transport, metabolism, and physiological responses. , 1999, The American journal of physiology.
[230] Y. Anikster,et al. Mutations of CTNS causing intermediate cystinosis. , 1999, Molecular genetics and metabolism.
[231] W. Gahl,et al. CTNS mutations in an American-based population of cystinosis patients. , 1998, American journal of human genetics.
[232] M. Palacín,et al. Molecular biology of mammalian plasma membrane amino acid transporters. , 1998, Physiological reviews.
[233] O. Gribouval,et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis , 1998, Nature Genetics.
[234] Y. Shigeri,et al. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. , 1998, Molecular pharmacology.
[235] K. Shimamoto,et al. New β-Hydroxyaspartate Derivatives Are Competitive Blockers for the Bovine Glutamate/Aspartate Transporter* , 1997, The Journal of Biological Chemistry.
[236] H. Daniel,et al. Target size analysis of the peptide/H(+)-symporter in kidney brush-border membranes. , 1995, Biochimica et biophysica acta.
[237] M. Romero,et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.
[238] T. Ishii,et al. Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancer. , 2017, American journal of translational research.
[239] S. Bröer. The SLC38 family of sodium–amino acid co-transporters , 2013, Pflügers Archiv - European Journal of Physiology.
[240] Y. Kanai,et al. Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters. , 2008, Journal of pharmacological sciences.
[241] F. Chaudhry,et al. Pharmacology of neurotransmitter transport into secretory vesicles. , 2008, Handbook of experimental pharmacology.
[242] J. Glazier,et al. SNAT4 isoform of system A amino acid transporter is expressed in human placenta. , 2006, American journal of physiology. Cell physiology.
[243] J. Matthews,et al. Recent advances in amino acid transporters and excitatory amino acid receptors. , 2002, Current opinion in clinical nutrition and metabolic care.
[244] H. Christensen,et al. Role of amino acid transport and countertransport in nutrition and metabolism. , 1990, Physiological reviews.